Ondansetron Tablet, Orally Disintegrating
Product Images NDC 68071-4115

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-4115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 4115 02 G86)

Pdp (68071 4115 02 G86)
Ondansetron 4 mg orally disintegrating tablets packaging label from NuCare Pharmaceuticals, Inc. The label shows the product name, dosage strength, and form (ODT tablets) with the NDC 68071-4115-2. It includes lot number, expiration date, active ingredient details, and warnings. The label also displays barcodes and prescription-only status.*
FDA Label Image

Structure-base (Structure Base)

Structure-base (Structure Base)
Chemical structure of ondansetron, showing the molecular arrangement including a fused aromatic ring system, a ketone group, and a methyl-substituted imidazole ring.*
FDA Label Image

Structure-hcl (Structure HCl)

Structure-hcl (Structure HCl)
Chemical structure of ondansetron hydrochloride dihydrate, showing its molecular arrangement with chlorine and water molecules indicated as HCl and 2H2O.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.